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Abstract
 
The serine/threonine-specific protein kinase C (PKC)-
 
  
 
is predominantly expressed in T cells
and localizes to the center of the immunological synapse upon T cell receptor (TCR) and CD28
signaling. T cells deficient in PKC-
 
  
 
exhibit reduced interleukin (IL)-2 production and prolifer-
ative responses in vitro, however, its significance in vivo remains unclear. We found that 
 
pkc-
 
 
 
 
 
/
 
 
 
mice were protected from pulmonary allergic hypersensitivity responses such as airway hyperre-
sponsiveness, eosinophilia, and immunoglobulin E production to inhaled allergen. Furthermore,
T helper (Th)2 cell immune responses against 
 
Nippostrongylus brasiliensis
 
 were severely impaired
in 
 
pkc-
 
 
 
 
 
/
 
  
 
mice. In striking contrast, 
 
pkc-
 
 
 
 
 
/
 
  
 
mice on both the C57BL/6 background and the
normally susceptible BALB/c background mounted protective Th1 immune responses and were
resistant against infection with 
 
Leishmania major
 
. Using in vitro TCR transgenic T cell–dendritic
cell coculture systems and antigen concentration-dependent Th polarization, PKC-
 
 
 
–deficient
T cells were found to differentiate into Th1 cells after activation with high concentrations of
specific peptide, but to have compromised Th2 development at low antigen concentration. The
addition of IL-2 partially reconstituted Th2 development in 
 
pkc-
 
 
 
 
 
/
 
  
 
T cells, consistent with an
important role for this cytokine in Th2 polarization. Taken together, our results reveal a central
role for PKC-
 
  
 
signaling during Th2 responses.
Key words: PKC-
 
  
 
• asthma • 
 
Leishmania
 
 • nippostrongylus • Th2 cell
 
Introduction
 
Activation of naive T cells in vivo involves a series of inter-
actions between APCs and T cells. Central to these interac-
tions is the presentation of antigen in the context of the
MHC to the TCR, and costimulation through nonpoly-
morphic molecules such as CD28. The integration of these
activation signals results in optimal T cell activation and full
transcription from the IL-2 promoter. Upon antigen stimu-
lation, many of the molecules involved in T cell activation
redistribute to focal points of T cell–APC interaction and
form what is commonly referred to as the immunological
synapse (1, 2). A key molecule associated with the immu-
nological synapse is protein kinase C (PKC)-
 
 
 
, which is a
novel Ca
 
2
 
 
 
-independent PKC isoform (3) that unlike the
eight other currently identified PKC isotypes (4), is specifi-
cally expressed in T cells and skeletal muscle (3). Through a
mechanism involving Vav, Rac, and actin cytoskeleton re-
organization (5), it localizes into the center of the immuno-
logical synapse and to lipid rafts after TCR stimulation and
CD28 costimulation (6–8). In addition, upon TCR stimu-
lation, the Src family protein tyrosine kinase, Lck, has been
shown to phosphorylate a tyrosine residue in the PKC-
 
 
 
regulatory domain, which is required for the translocation
of PKC-
 
  
 
to lipid rafts (9). Recent studies using T cells
from mice genetically deficient in PKC-
 
  
 
have shown that
its absence leads to reduced IL-2 production and IL-2 receptor
expression, with consequent impaired proliferative responses
(10, 11). Signaling through PKC-
 
  
 
is required for TCR-
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initiated induction of the transcription factors nuclear fac-
tor (NF)-
 
 
 
B and AP1 (10). Activation of NFAT has also
been reported to be compromised in one of the PKC-
 
 
 
–
deficient mouse strains (11). NF-
 
 
 
B–mediated transcrip-
tion has been linked to the development of Th2 cell im-
mune responses (12–14) as well as IFN-
 
  
 
(15) and IL-12
production (16). NFAT family members have also been
shown to have key roles in Th cell differentiation (17, 18),
as absence of NFATc1 and NFATc3 results in abnormal
Th2 cell polarization.
Although the molecular pathways of PKC-
 
 
 
–mediated
T cell activation continue to be delineated, the role of
PKC-
 
  
 
in the development of immune responses in vivo
has yet to be established. We have examined Th cell differ-
entiation in response to a variety of stimuli in mice geneti-
cally deficient for PKC-
 
 
 
, and have found that these ani-
mals have a profound defect in Th2 cell responses. PKC-
 
 
 
was found to be critical for the development of Th2 cell
immune responses after infection by the helminth 
 
Nippo-
strongylus brasiliensis
 
 (Nb) and for the response to inhaled al-
lergen in a model of atopic asthma. Its absence, however,
did not affect the production of IFN-
 
  
 
and Th1 cell–medi-
ated resistance against 
 
Leishmania major
 
 infection by PKC-
 
 
 
–deficient mice on a C57BL/6 background. These findings
highlight PKC-
 
  
 
as a central regulator in the development
of Th2 cell immune responses in vivo, and suggest that
PKC-
 
  
 
could be an important target for immunomodulat-
ing drugs.
 
Materials and Methods
 
Mice and Pathogens.
 
C57BL/6 and BALB/c wild-type mice
were obtained from Charles River Laboratories. PKC-
 
 
 
–defi-
cient mice were generated as described previously (10) and back-
crossed 
 
 
 
15 generations onto the C57BL/6 background and 
 
 
 
6
generations onto the BALB/c background. SMARTA-2 (LCMV
gp13 TCR transgenic) mice (provided by H. Hengartner, Insti-
tute of Experimental Immunology, Zurich, Switzerland) and
DO11.10 OVA-TCR transgenic mice (provided by K. Murphy,
Washington University School of Medicine, St. Louis, MO)
were backcrossed greater than six generations onto the C57BL/6
and BALB/c backgrounds, respectively. Mice were maintained
under specific pathogen-free conditions in BioSupport and Skir-
ball Institute animal facilities in isolated, ventilated cages. Animals
used in experiments were between 8 and 10 wk of age. Nb was
maintained by passage through Lewis rats (provided by N. Harris,
Institute of Experimental Immunology, Zurich, Switzerland).
Mice were infected subcutaneously with 550 live L3 worms and
killed at day 14 after infection. For infection with 
 
L. major
 
, sta-
tionary-phase promastigotes were collected from in vitro culture
in biphasic Novy-Nicolle-McNeal blood agar medium, and
1–2 
 
  
 
10
 
6 
 
parasites were injected subcutaneously into the right
hind footpad. The infection was monitored by measuring footpad
swelling with a metric caliper (Kroeplin). Mice were killed and
tissues were taken at the indicated time points. All animal experi-
mental procedures were approved by local animal committees
(Basel, Zurich and New York University Institutional Animal
Care and Use Committee).
 
OVA-induced Airway Inflammation.
 
Mice were immunized by
intraperitoneal injection with 100 
 
 
 
g OVA (grade V; Sigma-
Aldrich) in 200 
 
 
 
l of alum adjuvant (SERVA; Electrophoresis
GmbH). 7 d later, mice were challenged by intranasal (i.n.) inoc-
ulation with 100 
 
 
 
g OVA in 50 
 
 
 
l PBS.
 
Measurement of Airway Responsiveness.
 
On day 3 after i.n.
challenge with OVA, mice were placed in individual, unrestrained
whole body plethysmograph chambers (Buxco Electronics). Air-
way responsiveness was assessed in mice by inducing airflow ob-
struction with aerosolized methacholine chloride (MetCh). This
procedure estimates total pulmonary airflow in the upper and
lower respiratory tracts. The chamber pressure was used as a mea-
sure of the difference between thoracic expansion (or contraction)
and air volume removed from (or added to) the chamber during
inspiration (or expiration). Pulmonary airflow obstruction was as-
sessed by measuring PenH using BioSystem XA software (Buxco
Electronics). Measurements of MetCh responsiveness were ob-
tained by exposing mice for 3 min to incremental doses of aero-
solized MetCh (Aldrich Chemie) and monitoring the breathing
pattern for 5 min after initiation of aerosol dose.
 
Collection and Analysis of Bronchoalveolar Lavage (BAL) Cells.
 
On day 4 after i.n. challenge with OVA, mice were killed by
CO
 
2 
 
inhalation. The trachea was cannulated and BAL was per-
formed by flushing the airways three times with 1 ml PBS. Total
BAL cells were counted using a Coulter Counter (IG Instru-
ments) and spun onto glass slides using a Cytospin 2 (Shandon
Southern Products, Ltd.). After fixation with methanol for 2.5
min, cells were stained with undiluted May-Grünwald solution
(Fluka) for 3 min. An additional staining was performed in a 50%
May-Grünwald solution for 3 min. In a last step, cells were
stained in 7% Giemsa solution (Fluka) for 12 min. Slides were
rinsed with tap water and air-dried overnight. Dried cells were em-
bedded in Eukit solution (O. Kindler GmbH & Co.) under glass
coverslips. Percentages of macrophages, lymphocytes, neutro-
phils, and eosinophils were determined microscopically by count-
ing 200 cells/sample using standard morphological and cyto-
chemical criteria. Total numbers of eosinophils were derived by
multiplying the total number of leukocytes by the percentage of
eosinophils identified morphologically.
 
ELISA Measurement of Antibodies and IFN-
 
 
 
.
 
At indicated
time points, BAL fluid, serum, or culture supernatant was ana-
lyzed for either total IgE or IFN-
 
 
 
. 96-well plates (Maxisorp;
Nunc) were coated with anti-IgE at a concentration of 5 
 
 
 
g/ml,
or anti–IFN-
 
  
 
at 5 
 
 
 
g/ml in 50 
 
 
 
l PBS overnight at 4
 
 
 
C. Be-
tween each of the following steps, plates were washed five times
with PBS. Coated plates were blocked with PBS/1% BSA for 2 h
at room temperature. Samples from individual mice/cultures
were serially diluted in PBS/0.1% BSA as indicated, followed by
incubation at room temperature for 2 h. Thereafter, alkaline
phosphatase-labeled goat anti–mouse antibodies to IgE or IFN-
 
 
 
(Southern Biotechnology Associates, Inc.), respectively, were
added at room temperature for 2 h, followed by the addition of
the substrate 
 
p
 
-nitrophenyl phosphate (Sigma-Aldrich). OD was
determined at 405 nm.
 
Proliferation Assay.
 
A single cell suspension was made from the
indicated lymph nodes by gentle teasing through 70-
 
 
 
m nylon cell
strainers (Falcon). Cells were washed through the strainers with
IMDM into 50-ml (Falcon) tubes. Antigen at the indicated con-
centrations was diluted in 96-well plates and 5 
 
  
 
10
 
5 
 
cells were
added per well. Cells were cultured for 72 h at 37
 
 
 
C with [
 
3
 
H]thy-
midine added (1 
 
 
 
Ci/well) for the last 12 h. Total [
 
3
 
H]thymidine
incorporation was measured as an indicator of cell proliferation.
 
Intracellular Cytokine Staining and FACS
 
® 
 
Analysis.
 
Approxi-
mately 5 
 
  
 
10
 
5 
 
cells from either BAL samples or in vitro culture
were stimulated with either 10
 
 
 
7 
 
M PMA and 1 
 
 
 
g/ml ionomy- 
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cin, 5 
 
 
 
g/ml plate-bound anti-CD3, or antigen-pulsed DCs for
6 h at 37
 
 
 
C in IMDM medium. For the final 2 h, 10 
 
 
 
g/ml
brefeldin A was added to the cultures to retain cytokines in the
cytoplasm. Thereafter, cells were washed with PBS/0.1% BSA
and incubated with anti-CD32/CD16 mAb for 30 min at 4
 
 
 
C to
block Fc binding. After another washing step, cells were stained
with APC-labeled anti-CD4 mAb (BD Biosciences) for 15 min
at 4
 
 
 
C. Next, cells were washed with PBS/0.1% BSA, and then
again in PBS and fixed with 2% paraformaldehyde for 20 min at
room temperature. Fixed cells were then incubated in permeabi-
lization buffer (0.5% saponin/PBS/1% BSA) containing FITC-
labeled anti–IFN-
 
 
 
, anti–IL-10, and PE-labeled anti–IL-4 mAb
(BD Biosciences) for 30 min at room temperature. Cells were
washed twice in permeabilization buffer, and then resuspended in
PBS/1% BSA and analyzed by flow cytometry (FACSCalibur™;
Becton Dickinson) and FlowJo software (Tree Star, Inc.).
 
Determination of Parasite Load.
 
Infected BALB/c mice were
killed at 5 wk before lesions became necrotic. The lesions of
three mice were harvested, pooled, and homogenized, debris was
removed by brief centrifugation, and parasite numbers were de-
termined in triplicate by limiting dilution (19).
 
TCR Transgenic T Cell–DC Coculture.
 
Naive SMARTA-2
PKC-
 
 
 
 
 
/
 
  
 
and SMARTA-2 PKC-
 
 
 
    
 
mice were killed and
spleens were removed. CD4
 
  
 
T cells were isolated by MACS
bead separation (Miltenyi Biotec) and were found to be 90–95%
CD4
 
  
 
CD62L
 
high 
 
by subsequent FACS
 
® 
 
analysis. DCs were iso-
lated from naive wild-type C57BL/6 spleens as described previ-
ously (20). Isolated T cells (5 
 
  
 
10
 
4 
 
cells/well) and DCs (10
 
4
 
cells/well) were cultured in 96-well plates in the presence of ei-
ther 1,000 nM GP13 peptide for Th1 cell differentiation or 0.3
nM GP13 peptide for Th2 cell differentiation. In the indicated
cultures, a 1:200 dilution of supernatant from the recombinant
human IL-2–producing hybridoma, IL-2-t-6, was also added. On
day 3 of culture, cells were activated in the presence of PMA and
ionomycin for 4 h. IFN-
 
  
 
and IL-4 production was determined
by flow cytometry as described above.
 
Statistics.
 
Statistical significance was analyzed by the Student’s 
 
t
 
test. Unless otherwise indicated, data represents mean 
 
  
 
standard
deviation with P values of 
 
 
 
0.05 considered statistically significant.
 
Online Supplemental Material.
 
Fig. S1 shows IL-4 and IFN-
 
 
production in a DO11.10 TCR transgenic T cell–DC coculture
after activation with high and low doses of OVA peptide (amino
acids 323–339; Invitrogen). Fig. S1 is available at http://www.
jem.org/cgi/content/full/jem.20032229/DC1.
Results
PKC- –deficient Mice Have an Impaired Th2 Cell Immune
Response against Infection with Nb. It is clear from previous
in vitro studies that PKC-  is important for T cell activa-
tion and proliferation (10, 11), but its role in T cell activa-
tion during in vivo Th1 and Th2 cell immune responses
has yet to be investigated. We first sought to establish
whether PKC-  signaling was required for the develop-
ment of in vivo Th2 cell immune responses. To this end,
we examined the immune response mounted against the
prototypic Th2 cell–inducing helminth Nb by mice genet-
ically deficient in PKC- . Wild-type C57BL/6 control
mice and PKC- –deficient mice were infected s.c. with
Nb and 14 d later, serum and BAL fluid were examined for
IgE. Total IgE in both serum (Fig. 1 A) and BAL fluid (Fig.
1 B) was dramatically reduced in PKC- –deficient mice
compared with similarly infected wild-type controls, indi-
cating that PKC-  is required for IL-4–mediated (21) IgE
isotype switching. Next, we examined the infiltration of
eosinophils into the airways and blood, as this reflects in
vivo IL-5 cytokine activity (22, 23). As shown in Fig. 1 C,
the total number of eosinophils detected in the airways at
day 14 after infection was significantly reduced in PKC- –
deficient mice compared with wild-type controls. In addi-
tion, we examined the percentage of eosinophils circulating
in the blood at day 10 after infection and similarly found a
significantly reduced proportion of eosinophils (Fig. 1 D).
To ascertain whether the reduced eosinophil influx was
due to decreased IL-5 production by CD4  T cells, we
stimulated lymphocytes isolated from the airways with
PMA and ionomycin and determined the proportion of IL-
5–producing CD4  T cells 6 h later by flow cytometry. In
Figure 1. PKC- –deficient mice exhibit an impaired Th2 cell immune
response against infection with Nb. C57BL/6 and PKC- –deficient mice
were infected subcutaneously with Nb. On day 14 after infection, total
IgE in (A) serum and (B) BAL fluid was determined by ELISA. (C) The
total number of eosinophils that had infiltrated into the airways was also
determined on day 14. (D) On day 10 after infection, blood was taken
and the percentage of circulating eosinophils was determined. On day 14
after infection, (E) lymphocytes isolated from BAL fluid were activated
with PMA and ionomycin, and IL-5–producing CD4  T cells were de-
termined by flow cytometry, (F) mediastinal lymph nodes were removed,
and isolated lymphocytes were cultured in the presence of Nb antigens
for 72 h. [3H]thymidine incorporation over the last 12 h of culture was
measured as an indicator of cell proliferation. *, significant difference be-
tween groups (P   0.05). Data is from representative experiments using
four to five mice per group. Similar results were obtained in three inde-
pendent experiments.PKC-  Regulates Th2 Cell Responses 184
line with the reduced eosinophil infiltration, the propor-
tion of IL-5–producing CD4  T cells was reduced in
PKC- –deficient mice compared with wild-type controls
(Fig. 1 E). This data indicates that the impaired airway eo-
sinophilia is due to a defect in T cell function, rather than a
defect in the eosinophils per se. We then examined the
proliferative capacity of the cells responding to Nb infec-
tion. Lymphocytes were isolated from the draining medias-
tinal lymph node and cultured in vitro with DCs pulsed
with Nb antigens. Lymphocytes from PKC- –deficient
mice exhibited greatly impaired antigen-specific prolifera-
tion compared with similarly infected wild-type control
mice (Fig. 1 F). This finding is consistent with previously
published data that show that cells deficient in PKC-  have
reduced proliferation after stimulation with anti-CD3 (10).
Taken together, these data demonstrate that PKC-  plays a
key role in the induction of Th2 cell immune responses di-
rected against the helminth Nb.
PKC- –deficient Mice Fail to Develop Th2 Cell–dependent
Allergic Airway Inflammation. To establish whether the de-
fective Th2 cell immune response mounted against Nb in-
fection was also evident in other models of Th2 cell
immune responses, we examined the ability of PKC- –
deficient mice to develop an allergic airway response
against inhaled antigen. Mice were immunized by i.p. in-
jection of OVA adsorbed in alum adjuvant, and then chal-
lenged i.n. 7 d later with OVA in PBS. 4 d after the i.n.
challenge, serum and BAL fluid were examined for total
IgE. In line with the data shown in the previous experi-
ment, both serum (Fig. 2 A) and BAL (Fig. 2 B) IgE levels
were dramatically reduced in PKC- –deficient mice com-
pared with wild-type controls. In addition, we quantified
the number of eosinophils that had migrated into the air-
ways (Fig. 2 C) and lung parenchyma (not depicted) 4 d af-
ter OVA challenge and found that eosinophil migration
was similarly reduced in this model. The hallmark feature
of allergic asthma is the development of airway hyperre-
sponsiveness (AHR), in which the Th2 cell cytokine IL-13
plays a central role (24). Accordingly, we investigated the
development of AHR in PKC- –deficient mice. 3 d after
OVA i.n. challenge, mice were exposed to increasing doses
of aerosolized MetCh. OVA-sensitized and challenged
BALB/c control mice exhibited marked AHR that in-
creased with higher doses of MetCh (Fig. 2 D). However,
PKC- –deficient mice only exhibited mild sensitivity to
MetCh challenge (Fig. 2 D), indicating that this IL-13–
mediated component of the Th2 cell immune response was
also impaired. We sought to examine the proliferative ca-
pacity of OVA-specific lymphocytes. Lymphocytes were
isolated from the draining mediastinal lymph node 4 d after
OVA i.n. challenge and cultured in vitro with DCs pulsed
with OVA protein. The proliferative response of lympho-
cytes from PKC- –deficient mice was dramatically reduced
compared with wild-type controls (Fig. 2 E). Taken to-
gether, these data demonstrate that the Th2 cell effector re-
sponses induced in this model of atopic asthma are im-
paired in the absence of PKC-  signaling.
PKC- –deficient T Cells Exhibit Impaired IL-4 but Normal
IFN-  Production. Next, we examined ex vivo cytokine
production of effector CD4  T cells isolated from the air-
ways. Mice were sensitized to OVA adsorbed in alum adju-
vant and 7 d later were challenged i.n. with OVA in PBS.
4 d after i.n. challenge, lymphocytes from wild-type and
PKC- –deficient mice were isolated from the airways and
restimulated for 6 h with either OVA protein–pulsed DCs
(Fig. 3 A), plate-bound anti-CD3 (Fig. 3 B), or PMA and
ionomycin (Fig. 3 C). The proportion of CD4  T cells that
produced IL-4 and IFN-  was determined by flow cytom-
etry. A comparable proportion of wild-type CD4  T cells
Figure 2. PKC- –deficient mice
fail to develop Th2 cell–dependent
allergic airway inflammation. BALB/c
and PKC- –deficient mice were
sensitized to OVA by i.p. immuni-
zation of OVA protein adsorbed in
alum adjuvant and 7 d later, mice
were challenged i.n. with OVA pro-
tein in PBS. 4 d after challenge, total
IgE was determined in (A) serum
and (B) BAL fluid by ELISA. (C) The
number of eosinophils that had infil-
trated into the airways was also de-
termined on day 4 after i.n. challenge.
(D) On day 3 after i.n. challenge,
mice were exposed to increasing
doses of MetCh and AHR was de-
termined in a full body unrestrained
plethysmograph. (E) On day 4 after
i.n. challenge, mediastinal lymph
nodes were removed and isolated
lymphocytes were cultured in the
presence of OVA protein for 72 h.
[3H]thymidine incorporation over
the last 12 h of culture was measured
as an indicator of cell proliferation.
*, significant difference between
groups (P   0.05). Data is from rep-
resentative experiments using four to
five mice per group. Similar results
were obtained in three independent
experiments.Marsland et al. 185
produced either IL-4 or IFN-  after each type of activation
stimuli. In contrast, PKC- –deficient T cells failed to pro-
duce IL-4 after each of the activation stimuli examined
(Fig. 3). This lack of IL-4 production is consistent with the
reduced levels of IgE detected in both of the in vivo mod-
els tested. Taken together, these data indicate that although
PKC-  signaling is critically important for IL-4 production
and the development of Th2 cell immune responses, it is
not necessary for production of the prototypic Th1 cell cy-
tokine, IFN- .
PKC- –deficient Mice Develop a Protective Th1 Cell–mediated
Immune Response against Infection with L. major in Both the
Resistant C57BL/6 and Susceptible BALB/c Backgrounds.
We have established that PKC- –deficient mice exhibit im-
paired Th2 cell immune responses in vivo. To determine
whether PKC- –deficient mice exhibit a similar defect in
Th1 cell immune responses, we infected PKC- –deficient
mice with L. major, as resistance to this pathogen has clearly
been demonstrated to be dependent upon an effective Th1
cell immune response (25–27). In brief, the C57BL/6
mouse strain mounts a Th1 cell immune response after in-
jection of infectious L. major promastigotes and exhibits
swelling at the site of infection, which then resolves. In
comparison, mice on a BALB/c background mount a pre-
dominately Th2 cell immune response after infection and as
a result, fail to control parasite replication and display pro-
gressive swelling and necrosis of the lesion (28).
Mice were infected with 2   106 infectious L. major pro-
mastigotes in the hind footpad. Footpad swelling was mea-
sured in infected C57BL/6, BALB/c wild-type control,
and PKC- –deficient mice. As expected, wild-type BALB/
c mice exhibited progressive footpad swelling (Fig. 4 A)
and high parasite titre (Fig. 4 B). However, wild-type
C57BL/6 and PKC- –deficient mice on both C57BL/6
and BALB/c backgrounds were capable of mounting an ef-
fective Th1 cell immune response, as indicated by transient
footpad swelling (Fig. 4 A) and very low parasitemia (Fig. 4
B and not depicted). We continued to monitor PKC- –
deficient mice for as long as 9 mo after infection, and
no disease development was observed (unpublished data).
Next, we examined cytokine production by wild-type and
PKC- –deficient BALB/c mice after L. major infection. As
expected, a large proportion of CD4  T cells from wild-
type mice produced IL-4 and IL-10, but very little IFN- ,
consistent with failure to clear the infection (Fig. 4 C). In
contrast, PKC- –deficient mice on a BALB/c background
produced no IL-4 or IL-10, but did produce IFN-  (Fig. 4
C). We also measured the total amount of IFN-  produced
by wild-type and PKC- –deficient mice on C57BL/6
backgrounds by ELISA after 48 h of culture with L. major
antigens. In line with their similar resistance to L. major in-
fection, we found that comparable amounts of IFN-  were
produced in both wild-type and PKC- –deficient mice
(Fig. 4 D). Next, we examined antigen-specific prolifera-
tion of lymphocytes isolated from the popliteal lymph
node, and similarly found no difference between wild-type
and PKC- –deficient mice (Fig. 4 E). Thus, in striking
contrast to its requirement for development of in vivo Th2
cell responses, PKC-  signaling does not appear to be criti-
cal for the development of Th1 cell immune responses.
IL-2 Partially Restores Th2 Cell Differentiation of PKC- –
deficient T Cells in an In Vitro TCR Transgenic T Cell–DC
Coculture System. To ascertain whether PKC- –deficient
T cells were capable of differentiating into Th2 cells, we
used an in vitro TCR transgenic T cell–DC coculture sys-
tem. CD4  T cells were isolated from the spleens of naive
SMARTA2 TCR transgenic mice on a C57BL/6 wild-
type background or a PKC- –deficient background, and
cultured in the presence of primary DCs with either a high
(1,000 nM) or low (0.3 nM) concentration of GP13 pep-
tide. We have recently shown that high antigen concentra-
tion promotes differentiation of IFN- –producing Th1
cells through up-regulation of CD40L on naive CD4  T
cells and CD40–mediated IL-12 production by DCs,
Figure 3. PKC- -deficient CD4  T
cells have impaired IL-4 but normal
IFN-  production. BALB/c and PKC- –
deficient mice were immunized and
challenged with OVA as described in
Fig. 2. 4 d after challenge, BAL was
performed and lymphocytes were iso-
lated. Lymphocytes were cultured with
(A) DCs pulsed with OVA protein, (B)
plate-bound anti-CD3, or (C) PMA
and ionomycin for 6 h at 37 C. The
proportion of cells producing IL-4 and
IFN-  was determined by intracellular
cytokine staining and flow cytometry.
Dot plots are gated on CD4  lympho-
cytes as determined by forward and side
scatter properties and positive staining
for CD4. Numbers represent percent-
age of CD4  T cells in each quadrant
and are representative of each group.
Similar results were obtained in three
independent experiments with four to
five mice per group.PKC-  Regulates Th2 Cell Responses 186
whereas low antigen concentration leads to the differentia-
tion of IL-4–producing Th2 cells (20). After 3 d of culture,
cells were activated with PMA and ionomycin for 4 h and
the proportion of CD4  T cells producing IFN-  and IL-4
was determined by flow cytometry. When cells were acti-
vated with 1,000 nM GP13 peptide, wild-type cells differ-
entiated with high frequency selectively into Th1 cells
(IFN-   IL-4 ), which was comparable in PKC- –defi-
cient cells (Fig. 5 A). However, although wild-type
SMARTA2 T cells differentiated into predominantly Th2
(IL-4  IFN-  ) cells after activation with 0.3 nM GP13
peptide, PKC- –deficient SMARTA2 T cells failed to dif-
ferentiate into IL-4–producing cells and remained mainly
undifferentiated (IL-4low IFN- low) cells (Fig. 5 B). IL-2 is
important for T cell proliferation and also plays a role in
Th2 cell differentiation (29). Considering that PKC- –
deficient mice exhibit impaired IL-2 production and up-
regulation of CD25 (10), one likely mechanism underlying
the impaired Th2 cell differentiation could be the reduced
level of IL-2. Accordingly, we investigated whether the ad-
dition of IL-2 into the coculture system could restore Th2
Figure 4. PKC- –deficient
mice exhibit a Th1 cell immune
response after infection with L.
major. C57BL/6, BALB/c, and
PKC- –deficient mice on a
C57BL/6 or BALB/c background
were infected with 2   106 pro-
mastigotes of L. major in the hind
footpad. (A) At the indicated
time points, the course of disease
was monitored using metric calli-
pers to determine footpad swell-
ing. (B) 5 wk after infection, le-
sions from infected footpads were
removed and parasite load was
determined. (C) Lymphocytes
were isolated from popliteal
lymph nodes draining the in-
fected footpads and cultured in
the presence of soluble L. major
antigens for 72 h. (C) Cultured
lymphocytes from BALB/c
wild-type and PKC- –deficient
mice were restimulated with
PMA and ionomycin for 4 h and
the proportion of CD4  T cells
producing IFN- , IL-10, and
IL-4 was determined by flow cy-
tometry. Numbers represent
percentage of cytokine  cells in
each quadrant. (D) IFN-  levels
in the supernatant of cultured
lymphocytes from C57BL/6
wild-type and PKC- –deficient
mice were determined by ELISA
after 48 h of stimulation with
soluble  L. major antigens. (D)
Lymphocytes  isolated from the
popliteal lymph node were cul-
tured in the presence of soluble
L. major antigens for 72 h.
[3H]thymidine incorporation over
the last 12 h of culture was mea-
sured as an indicator of cell pro-
liferation. Data is from represen-
tative experiments using three to
five mice per group. Similar data
was obtained in two indepen-
dent experiments.
Figure 5. IL-2 partially restores Th2 cell differentiation in an in vitro
TCR transgenic T cell–DC coculture system. PKC-     and PKC-    
SMARTA-2 TCR transgenic CD4  T cells were cultured with C57BL/6
primary DCs in the presence of GP13 peptide for 3 d as described in
Materials and Methods. After a 4-h restimulation with PMA and ionomycin,
IFN- – and IL-4–producing TCR transgenic T cells were identified by
flow cytometry. (A) Cells were activated with 1,000 nM GP13 peptide for
Th1 cell differentiation. (B) Cells were activated with 0.3 nM GP13 pep-
tide for Th2 cell differentiation. (C) On day 0, IL-2 was added to cultures
stimulated with 0.3 nM GP13 peptide. Numbers represent percentage of
CD4  T cells in each quadrant. Data is from one representative experi-
ment and similar data was obtained in two independent experiments.Marsland et al. 187
cell differentiation in PKC- –deficient mice. Fig. 5 C
shows that indeed the addition of IL-2 resulted in increased
production of IL-4 by PKC- –deficient T cells, although
not to the level of wild-type cells. In a BALB/c DO11.10
transgenic T cell–DC coculture system, we similarly found
that PKC- –deficient mice exhibited impaired Th2 cell
differentiation, and this was partially restored by the addi-
tion of exogenous IL-2 (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20032229/DC1). These data
further highlight the specific impairment of Th2 cell im-
mune responses in the absence of PKC- .
Discussion
In this work we have demonstrated that PKC-  is re-
quired for in vivo development of Th2 cell– but not Th1
cell–dependent immune responses. PKC- –deficient mice
exhibited a highly impaired Th2 cell immune response
against the helminth Nb, as shown by reduced IL-4–
dependent IgE antibody production and IL-5–dependent
blood and airway eosinophilia. In addition, and as expected
from published in vitro observations, antigen-specific T cell
proliferation was also significantly impaired after ex vivo
restimulation. In support of these data, PKC- –deficient
mice failed to develop allergic airway inflammation, IgE
antibody responses, and AHR in a model of atopic asthma.
A key finding was that although IL-4 production was selec-
tively impaired in PKC- –deficient mice, a comparable
number of antigen-specific CD4  T cells from PKC- –
deficient mice and wild-type controls produced IFN- .
This finding was supported by the observation that the Th1
cell response against L. major infection was not affected by
the absence of PKC- , although the Th2 cell response was
compromised. Resolution of footpad swelling, parasite ti-
ter, IFN-  production, and proliferation in response to L.
major antigen were similar in PKC- –deficient and control
C57BL/6 mice. Moreover, in BALB/c mice, which are
normally susceptible to infection due to an early IL-4 re-
sponse, resolution of footpad swelling was observed in ani-
mals lacking PKC- , further demonstrating the failure of a
Th2 cell response to the parasite.
PKC-  is required for activation of the transcription fac-
tors NF- B and AP-1 after TCR ligation (10). Both tran-
scription factors have been implicated in Th cell develop-
ment. NF- B family members regulate IFN-  and IL-12 as
well as Th2 cell cytokine expression (12–16), whereas AP-1,
specifically Jun B, activates IL-4 expression in conjunc-
tion with c-MAF (30). However, both transcription factors
are also required for IL-2 expression, which is severely
compromised in PKC- –deficient T cells (10). Extensive
evidence points to a role for IL-2 in regulation of Th2 cell
cytokine responses. Le Gros et al. (29) originally showed
that IL-2 production enhances the development of Th2
cells. This result was consistent with the finding that in vivo
blockade of IL-2 resulted in resistance to L. major infection
in normally susceptible BALB/c mice (31). IL-2 is required
for IL-4 expression in vitro (29, 32, 33) and has recently
been demonstrated to stabilize chromatin accessibility for
STAT5 binding to the il4 gene, suggesting that it functions
to maintain transcriptional activity at the il4 locus (34). In-
terestingly, IFN-  expression appears to be less sensitive to
the levels of IL-2, as mice treated with anti–IL-2 antibodies
or lacking PKC-  express sufficient levels of IFN-  to com-
bat L. major infection (Fig. 4 and reference 31). Anti–IL-2
treatment also inhibited IL-4 expression in DO11.10 TCR
transgenic T cells stimulated in vivo (34). Our in vitro T
cell stimulation experiments demonstrate that IL-4 expres-
sion is partially rescued by the addition of exogenous IL-2
(Fig. 5). Therefore, failure to produce IL-2 might be a cen-
tral mechanism underlying the impaired Th2 cell immune
responses found in PKC- –deficient mice.
Because exogenous IL-2 failed to fully restore differenti-
ation of PKC- –deficient Th2 cells, other pathways in-
volved in Th1 cell differentiation may additionally be com-
promised in the mutant mice. In mice lacking the guanine
nucleotide exchange factor Vav, which has been reported
to interact with PKC- , there was also reduced IL-4
mRNA, but normal IFN-  mRNA, in draining lymph
nodes after immunization (35). A similar phenotype to the
one described in this work was found for Itk-deficient mice
(36), in which development of the Th2 cell immune re-
sponses against Nb and L. major were impaired, whereas
Th1 cell responses were normal. Although no direct associ-
ation between Itk and PKC-  has thus far been described,
the strikingly similar phenotype of these mice suggests that
these pathways of Th2 cell induction intersect. Moreover,
Btk was reported to be associated with PKC-  in B cells,
suggesting that Tec family kinases and PKCs may function
in the same signaling pathway (37). Therefore, the defect in
the PKC- –deficient mice might be due to interruption of
signals mediated through Itk and Vav after TCR and/or
CD28 ligation. It is possible, however, that the impaired in
vivo and in vitro Th2 cell responses of Itk-deficient mice
may also be due to reduced levels of IL-2 (36). In these
mice, the reduced expression of IL-2 was shown to be due,
at least in part, to defective activation of NFAT. Thus, the
impaired Th2 cell development observed in both ITK and
PKC- –deficient mice may derive from reduced IL-2 ex-
pression rather than from defects in PKC- –derived signals
to activate the il4 locus.
PKC-  and the CD28 costimulatory pathway closely in-
teract in the activation of T cells. PKC-  requires CD28
signaling to localize into the center of the mature immuno-
logical synapse (7) and is thought to integrate TCR and
CD28 signals, leading to complete T cell activation (38).
Ectopic expression of the serine-threonine kinase Akt in
CD28-deficient mice has been shown to compensate for
some of the costimulatory signal that is provided by CD28.
Specifically, Kane et al. (39) were able to reconstitute IFN- 
production, but not IL-4 or IL-5, by ectopic expression of
Akt in CD28-deficient mice. These data are similar to the
specific impairment of IL-4 and IL-5 production that we
describe in this work, raising the possibility that although ei-
ther Akt-mediated signaling or PKC- –mediated signalingPKC-  Regulates Th2 Cell Responses 188
might be sufficient to induce Th1 cell immune responses,
Th2 cell immune responses require a productive interaction
between the two molecules. Such ectopic expression of Akt
may not have been adequate for the integration of PKC- 
into the immunological synapse, or its Lck-mediated activa-
tion, and consequently resulted in impaired production of
Th2 cell cytokines. Indeed, PKC-  and Akt have been re-
ported to physically associate upon T cell activation and to
activate the NF- B signaling pathway (40).
Whether loss of PKC-  may directly affect Th2 cell cy-
tokine gene expression remains unclear. Earlier studies
have implicated members of the NF- B and NFAT fami-
lies of transcription factors in regulation of Th1 and Th2
cell differentiation. Although NF- B family members have
been reported to regulate the expression of both Th1 (15,
16) and Th2 cell cytokines (12–14), IL-4 production and
Th2 cell–dependent airway eosinophil responses were
compromised in mice lacking expression of the p50 subunit
of NF- B (12, 14). In these mice, IFN-  production was
comparable to levels in wild-type animals (14). Because
PKC-  is required for NF- B activation after TCR liga-
tion, impairment of this pathway in mutant mice may ex-
plain, at least in part, the defect in Th2 cell cytokine regu-
lation. The role of NFAT signaling in the observed Th2
cell defect in the PKC- –deficient mice is more difficult to
interpret. Although we did not observe a defect in NFAT
activation in T cells from mutant mice, another group re-
ported impaired nuclear NFAT DNA binding activity in a
different strain of pkc  /  mice. Even if NFAT signaling
were defective, the observed reduction in IL-4 levels can-
not be readily explained by current literature, which impli-
cates members of the NFAT family in both positive and
negative regulation of expression of the cytokine. More-
over, NFAT proteins often associate with AP-1 hetero-
dimers to bind to composite sites in regulatory regions of
cytokine genes, and the defective AP-1 activation in
PKC- –deficient mice may therefore contribute to the im-
paired Th2 cell polarization.
Although PKC-  may play a synergistic role in the trans-
duction of both Th1 and Th2 cell activation signals, our data
indicate that it might be a central regulator of Th2 cell im-
mune responses, whereas Th1 cell responses are maintained
in its absence through alternate pathways. In purified PKC-
 –deficient T cells, induction of IFN-  was enhanced even
in the absence of proliferation, and after 2 h of anti-TCR
stimulation we observed higher levels of IFN-  mRNA in
CD4  cells from mutant versus control mice (unpublished
data). These results suggest that the mutant T cells have an
intrinsic propensity to express this Th1 cell cytokine. How-
ever, we did not observe enhanced Th1 cell responses in
vivo in the mutant animals, and we cannot rule out that
other factors, such as proinflammatory cytokines, sustain
normal Th1 cell responses in the absence of PKC- . In an in
vivo setting, the inflammatory cytokine milieu, strong
costimulatory signals and activation of Toll-like receptor
pathways may bypass the requirement for PKC-  in T cell
activation and differentiation during Th1 cell–inducing in-
fections, whereas signals induced during helminth infection
or allergic asthma might not be sufficient to bypass the re-
quirement for PKC-  in Th2 cell immune responses.
In summary, the experiments detailed in this work show
that PKC-  is critical for the development of in vivo Th2
cell immune responses. These data highlight PKC-  as a
potentially important target in therapy against Th2 cell–
related diseases.
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